STOCK TITAN

IDEAYA to Participate in Upcoming February 2021 Investor Relations Events

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

IDEAYA Biosciences (Nasdaq: IDYA) announced its participation in two key investor relations events in February 2021. The Guggenheim Healthcare Talks 2021 Oncology Day will include a fireside chat with analyst Michael Schmidt on February 12 at 12:00 pm ET, while the LifeSci Partners Precision Oncology Event is scheduled for February 17 at 2:00 pm ET. Live audio webcasts of both presentations will be accessible on the IDEAYA website and will be available for replay for 30 days.

Positive
  • None.
Negative
  • None.

SOUTH SAN FRANCISCO, Calif., Feb. 1, 2021 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced its participation at the following upcoming investor relations events.

Investor Relations Events

  • Guggenheim Healthcare Talks 2021 Oncology Day (Virtual)
    Fireside Chat with Analyst Michael Schmidt
    Friday, February 12th, 2021 at 12:00 pm ET
     
  • LifeSci Partners Precision Oncology Event (Virtual)
    Company Presentation
    Wednesday, February 17th, 2021, at 2:00pm ET

A live audio webcast of each presentation will be available by visiting the "Investors/News and Events/Investor Calendar" section of the IDEAYA website at https://ir.ideayabio.com/news-events/investor-calendar.  A replay of the webcasts will be available for 30 days following the live event.

About IDEAYA Biosciences
IDEAYA is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics.  IDEAYA's approach integrates capabilities in identifying and validating translational biomarkers with small molecule drug discovery to select patient populations most likely to benefit from the targeted therapies IDEAYA is developing.  IDEAYA is applying these capabilities across multiple classes of precision medicine, including synthetic lethality – which represents an emerging class of precision medicine targets. 

Forward-Looking Statements
This press release contains forward-looking statements, including, but not limited to, statements related to participation in and/or presentation at certain investor relations events. IDEAYA undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of IDEAYA in general, see IDEAYA's recent Quarterly Report on Form 10-Q filed on November 12, 2020 and any current and periodic reports filed with the U.S. Securities and Exchange Commission.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/ideaya-to-participate-in-upcoming-february-2021-investor-relations-events-301218475.html

SOURCE IDEAYA Biosciences, Inc.

FAQ

What investor events will IDEAYA participate in February 2021?

IDEAYA Biosciences will participate in the Guggenheim Healthcare Talks 2021 Oncology Day on February 12 and the LifeSci Partners Precision Oncology Event on February 17.

When is the Guggenheim Healthcare Talks 2021 Oncology Day?

The Guggenheim Healthcare Talks 2021 Oncology Day is scheduled for February 12, 2021, at 12:00 pm ET.

When is the LifeSci Partners Precision Oncology Event?

The LifeSci Partners Precision Oncology Event will take place on February 17, 2021, at 2:00 pm ET.

Where can I watch the IDEAYA investor presentations?

The presentations can be viewed live on the IDEAYA website under the Investors/News and Events/Investor Calendar section.

Will the IDEAYA presentations be available for replay?

Yes, a replay of the presentations will be available for 30 days after the live events.

IDEAYA Biosciences, Inc.

NASDAQ:IDYA

IDYA Rankings

IDYA Latest News

IDYA Stock Data

2.37B
85.54M
1.04%
110.9%
10.78%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SOUTH SAN FRANCISCO